COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

A National Phase IV Study With Ipilimumab for Patients With Advanced Malignant Melanoma. (Ipi4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02068196
Recruitment Status : Active, not recruiting
First Posted : February 21, 2014
Last Update Posted : March 4, 2020
Information provided by (Responsible Party):
Tormod Kyrre Guren, Oslo University Hospital

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2026